BioRestorative Therapies Inc (BRTX) vs. Its Peers: A Comparison
Additionally, the 36-month beta value for BRTX is 0.27. There are mixed opinions on the stock, with 1 analysts rating it as a “buy”, 1 rating it as “overweight”, 0 rating it as “hold”, and 0 rating it as “sell”. The public float for BRTX is 6.89M and currently, short sellers hold a 1.92% ratio … Read more